GlassScriptPhysician profile
Peter J Vassallo
NPI 1760429773
$8,757.17
in general payments reported to CMS, 2019-2025
45 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $1,348 · 2021: $1,148 · 2022: $1,190 · 2023: $1,115 · 2024: $1,411 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,659.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,378.50 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $850.26 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $724.02 | 2019-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $668.21 | 2019-2023 | Xarelto |
| Pfizer INC. | $602.51 | 2019-2025 | |
| Amgen INC. | $581.60 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.90 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $341.18 | 2022-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Merck Sharp & Dohme LLC | $318.11 | 2021-2025 | Verquvo |
| Irhythm Technologies, INC. | $301.60 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $288.26 | 2019-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $261.95 | 2019-2024 | |
| Abiomed | $251.02 | 2022-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $200.00 | 2021-2025 | |
| Esperion Therapeutics, INC. | $194.70 | 2020-2025 | Nexletol |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $163.28 | 2023-2024 | |
| Atricure, INC. | $133.55 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $131.76 | 2021-2025 | Cardiomems, Amplatzer Amulet |
| Medtronic, INC. | $98.32 | 2022-2023 | Onyx Frontier |
| Lundbeck LLC | $83.53 | 2019-2020 | |
| Amarin Pharma, INC. | $58.16 | 2020-2021 | |
| Cardiva Medical, INC. | $52.68 | 2023-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Daiichi Sankyo INC. | $52.47 | 2020-2023 | Injectafer |
| Novo Nordisk INC | $52.06 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $51.27 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $45.63 | 2019-2024 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $35.13 | 2023-2024 | Inpefa |
| Braemar Manufacturing, LLC | $33.07 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Uptravi, Opsumit |
| Baxter Healthcare | $30.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $28.74 | 2024 | Arcalyst |
| Philips North America LLC | $26.54 | 2019-2023 | |
| G Medical Diagnostic Services, INC. | $25.06 | 2022 | |
| Kestra Medical Technology Services, INC. | $21.76 | 2024 | Assure Wcd |
| Biotronik INC. | $21.51 | 2022 | |
| Glaxosmithkline, LLC. | $20.30 | 2025 | Shingrix, Arexvy |
| Agepha Pharma Fz LLC | $17.45 | 2025 | Lodoco |
| Altathera Pharmaceuticals LLC | $15.62 | 2025 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $15.40 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $15.15 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $14.90 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $14.42 | 2022 | |
| Bardy Diagnostics, INC. | $13.37 | 2022 | |
| Chiesi USA, INC. | $12.83 | 2019 | |
| Gilead Sciences, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Vassallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.